FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3170154262> ?p ?o ?g. }

• W3170154262 endingPage "351" @default.
• W3170154262 startingPage "345" @default.
• W3170154262 abstract "To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real-world setting.The post-marketing study involved 15 sites in Japan. Dydrogesterone 10 mg twice daily orally was administered for 21 days (day 5-25 of each menstrual cycle) for 4 cycles. The primary outcome measure was the change in ovarian endometrioma volume from baseline. Secondary outcome measures included total dysmenorrhea score (0 = absent to 3 = severe), severity of dysmenorrhea pain [0-10cm visual analog scale (VAS)], serum carbohydrate antigen 125 (CA-125) levels, and safety.The study group comprised women with an endometrioma aged 20 to 49 (47.4% cases aged ≥40 years). Endometrioma volume was reduced in 50% (26/52), unchanged in 25% (13/52), and increased in 25% (13/52) of women from baseline to the end of cycle 5; three-quarters of patients thus had either reduced or unchanged ovarian endometrioma volume. Dydrogesterone significantly reduced total dysmenorrhea scores and severity of dysmenorrhea pain VAS during treatment compared with baseline. CA-125 levels were not significantly changed during the study. The incidence of adverse events and adverse drug reactions in 59 subjects was 13.6% and 11.9%.Dydrogesterone prevented an increase in endometrioma size in many women, and it also significantly improved total dysmenorrhea scores and severity of dysmenorrhea pain, and was well tolerated. The ClinicalTrials.gov identifier of the study was NCT02921763." @default.
• W3170154262 created "2021-06-22" @default.
• W3170154262 creator A5020255729 @default.
• W3170154262 creator A5035620676 @default.
• W3170154262 creator A5077240475 @default.
• W3170154262 creator A5088687482 @default.
• W3170154262 date "2021-06-04" @default.
• W3170154262 modified "2023-10-16" @default.
• W3170154262 title "An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study" @default.
• W3170154262 cites W1523117771 @default.
• W3170154262 cites W1815118832 @default.
• W3170154262 cites W1860336910 @default.
• W3170154262 cites W1929676842 @default.
• W3170154262 cites W1964654662 @default.
• W3170154262 cites W1977001276 @default.
• W3170154262 cites W1990949887 @default.
• W3170154262 cites W2012650501 @default.
• W3170154262 cites W2018029119 @default.
• W3170154262 cites W2048674580 @default.
• W3170154262 cites W2061289968 @default.
• W3170154262 cites W2076623151 @default.
• W3170154262 cites W2108969631 @default.
• W3170154262 cites W2117844445 @default.
• W3170154262 cites W2140713069 @default.
• W3170154262 cites W214103652 @default.
• W3170154262 cites W2141979474 @default.
• W3170154262 cites W2147856649 @default.
• W3170154262 cites W2166974601 @default.
• W3170154262 cites W2180080828 @default.
• W3170154262 cites W2228635764 @default.
• W3170154262 cites W2402738652 @default.
• W3170154262 cites W2528775644 @default.
• W3170154262 cites W2752637078 @default.
• W3170154262 cites W2872842744 @default.
• W3170154262 cites W2892700451 @default.
• W3170154262 cites W4211092896 @default.
• W3170154262 doi "https://doi.org/10.1002/rmb2.12391" @default.
• W3170154262 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8254175" @default.
• W3170154262 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34262403" @default.
• W3170154262 hasPublicationYear "2021" @default.
• W3170154262 type Work @default.
• W3170154262 sameAs 3170154262 @default.
• W3170154262 citedByCount "3" @default.
• W3170154262 countsByYear W31701542622022 @default.
• W3170154262 crossrefType "journal-article" @default.
• W3170154262 hasAuthorship W3170154262A5020255729 @default.
• W3170154262 hasAuthorship W3170154262A5035620676 @default.
• W3170154262 hasAuthorship W3170154262A5077240475 @default.
• W3170154262 hasAuthorship W3170154262A5088687482 @default.
• W3170154262 hasBestOaLocation W31701542623 @default.
• W3170154262 hasConcept C126322002 @default.
• W3170154262 hasConcept C131872663 @default.
• W3170154262 hasConcept C141071460 @default.
• W3170154262 hasConcept C14184104 @default.
• W3170154262 hasConcept C197934379 @default.
• W3170154262 hasConcept C2776045411 @default.
• W3170154262 hasConcept C2776210078 @default.
• W3170154262 hasConcept C2776600139 @default.
• W3170154262 hasConcept C2777164284 @default.
• W3170154262 hasConcept C2777688143 @default.
• W3170154262 hasConcept C2779058012 @default.
• W3170154262 hasConcept C2779234561 @default.
• W3170154262 hasConcept C2779522080 @default.
• W3170154262 hasConcept C29456083 @default.
• W3170154262 hasConcept C54355233 @default.
• W3170154262 hasConcept C71315377 @default.
• W3170154262 hasConcept C71924100 @default.
• W3170154262 hasConcept C86803240 @default.
• W3170154262 hasConceptScore W3170154262C126322002 @default.
• W3170154262 hasConceptScore W3170154262C131872663 @default.
• W3170154262 hasConceptScore W3170154262C141071460 @default.
• W3170154262 hasConceptScore W3170154262C14184104 @default.
• W3170154262 hasConceptScore W3170154262C197934379 @default.
• W3170154262 hasConceptScore W3170154262C2776045411 @default.
• W3170154262 hasConceptScore W3170154262C2776210078 @default.
• W3170154262 hasConceptScore W3170154262C2776600139 @default.
• W3170154262 hasConceptScore W3170154262C2777164284 @default.
• W3170154262 hasConceptScore W3170154262C2777688143 @default.
• W3170154262 hasConceptScore W3170154262C2779058012 @default.
• W3170154262 hasConceptScore W3170154262C2779234561 @default.
• W3170154262 hasConceptScore W3170154262C2779522080 @default.
• W3170154262 hasConceptScore W3170154262C29456083 @default.
• W3170154262 hasConceptScore W3170154262C54355233 @default.
• W3170154262 hasConceptScore W3170154262C71315377 @default.
• W3170154262 hasConceptScore W3170154262C71924100 @default.
• W3170154262 hasConceptScore W3170154262C86803240 @default.
• W3170154262 hasIssue "3" @default.
• W3170154262 hasLocation W31701542621 @default.
• W3170154262 hasLocation W31701542622 @default.
• W3170154262 hasLocation W31701542623 @default.
• W3170154262 hasLocation W31701542624 @default.
• W3170154262 hasOpenAccess W3170154262 @default.
• W3170154262 hasPrimaryLocation W31701542621 @default.
• W3170154262 hasRelatedWork W2018029119 @default.
• W3170154262 hasRelatedWork W2235074483 @default.
• W3170154262 hasRelatedWork W2338788197 @default.
• W3170154262 hasRelatedWork W2356476264 @default.
• W3170154262 hasRelatedWork W2360993163 @default.

• next